BIS-(DIETHYLAMINOHYDROXYBENZOYL BENZOYL) PIPERAZINE (NANO)
1,1'-(1,4-piperazinediyl)bis[1-[2-[4-(diethylamino)-2-hydroxybenzoyl]phenyl]-methanone
BIS-(DIETHYLAMINOHYDROXYBENZOYL BENZOYL) PIPERAZINE (NANO) appears in Annex VI as a positive-list UV filter entry for EU cosmetics. Maximum concentration in this record: 10 % (In case of combined use of Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine and Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (nano), the sum shall not exceed 10 %)..
Record details
Maximum concentration
10 % (In case of combined use of Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine and Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (nano), the sum shall not exceed 10 %).
Other restrictions
Only nanomaterials having the following characteristics are allowed:
— Purity ≥ 97 %
—Median particle size D50 (50 % of the number below this diameter): ≥ 50 nm of number size distribution.
Not to be used in applications that may lead to exposure of the end user’s lungs by inhalation.
INCI glossary name
BIS-(DIETHYLAMINOHYDROXYBENZOYL BENZOYL) PIPERAZINE (NANO)
Chemical name
1,1'-(1,4-piperazinediyl)bis[1-[2-[4-(diethylamino)-2-hydroxybenzoyl]phenyl]-methanone
Chemical / IUPAC name
1,1'-(1,4-piperazinediyl)bis[1-[2-[4-(diethylamino)-2-hydroxybenzoyl]phenyl]-methanone
Regulatory information
Regulation
(EU) 2022/2195
Identified ingredients
Key data
Inventory links for BIS-(DIETHYLAMINOHYDROXYBENZOYL BENZOYL) PIPERAZINE (NANO)
BIS-(DIETHYLAMINOHYDROXYBENZOYL BENZOYL) PIPERAZINE
Related records for BIS-(DIETHYLAMINOHYDROXYBENZOYL BENZOYL) PIPERAZINE (NANO)
Direct matches are limited for this record, so nearby entries from Annex VI are shown as well.
BIS-(DIETHYLAMINOHYDROXYBENZOYL BENZOYL) PIPERAZINE
Methoxypropylamino Cyclohexenylidene Ethoxyethylcyanoacetate
PHENYLENE BIS-DIPHENYLTRIAZINE
TRIS-BIPHENYL TRIAZINE / TRIS-BIPHENYL TRIAZINE (NANO)
DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE
TITANIUM DIOXIDE
TITANIUM DIOXIDE (NANO)
BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE
What Annex VI means for BIS-(DIETHYLAMINOHYDROXYBENZOYL BENZOYL) PIPERAZINE (NANO)
BIS-(DIETHYLAMINOHYDROXYBENZOYL BENZOYL) PIPERAZINE (NANO) is an approved UV filter listed in Annex VI of EU Cosmetics Regulation 1223/2009. Only UV filters included in this positive list may be used to provide UV protection in EU cosmetic products.
The maximum permitted concentration specified in this entry applies to the ready-to-use product. Some UV filters are restricted to specific application types or require label warnings.
This record is linked to 1 CosIng inventory ingredient for name and identifier cross-reference. The page also surfaces 11 related annex records with overlapping identifiers, annex logic or naming patterns.
Compliance checklist
- Concentration in ready-to-use product must not exceed: 10 % (In case of combined use of Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine and Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (nano), the sum shall not exceed 10 %).
- Check whether the UV filter is approved for both leave-on and rinse-off applications.
Frequently asked questions
Source note for Annex VI record BIS-(DIETHYLAMINOHYDROXYBENZOYL BENZOYL) PIPERAZINE (NANO)
This page summarizes one Annex VI record for BIS-(DIETHYLAMINOHYDROXYBENZOYL BENZOYL) PIPERAZINE (NANO) from public European Commission cosmetic materials and adds linked inventory or identifier matches when available.
Use this record page to review Annex VI conditions for BIS-(DIETHYLAMINOHYDROXYBENZOYL BENZOYL) PIPERAZINE (NANO), but confirm any final regulatory decision against the current official annex wording and source files.
Tools & next steps
Check your formula
Paste a full INCI list to detect BIS-(DIETHYLAMINOHYDROXYBENZOYL BENZOYL) PIPERAZINE (NANO) and other flagged EU annex records in one pass.
INCI CheckerCompare entries
Compare BIS-(DIETHYLAMINOHYDROXYBENZOYL BENZOYL) PIPERAZINE (NANO) side by side with another annex record to review differences in restrictions, concentrations and annex placement.
CompareBrowse the annex
See all records in Annex VI and compare regulatory conditions across substances in this annex.
Open Annex VI